Skip to content

H.B. Fuller

US · FUL #2581 by market cap Listed 1970
46.24 -1.33 -2.80%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Below fair value
55.03 fair value ≈ 67.12 79.22
  • Implied fair-value range of 55.03-79.22, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -31.1% below the average-multiple fair value of 67.12.

Valuation each multiple against its own 5-year range

P/B ratio 1.22 Cheap vs history 0th percentile
5-year average 2.05 · #17 of 59 in Specialty Chemicals
P/E ratio 13.73 Cheap vs history 0th percentile
5-year average 24.41 · forward 12.18 · #6 of 36 in Specialty Chemicals
P/S ratio 0.75 Cheap vs history 0th percentile
5-year average 1.02 · forward 0.70 · #18 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
H.B. Fuller (FUL) 2.49B 12.88 1.15 2.08%
Linde (LIN) 230.84B 33.39 5.86 1.25%
Ecolab (ECL) 82.65B 40.10 7.93 0.99%
Sherwin-Williams (SHW) 82.08B 31.25 20.64 0.94%
Air Products & Chemicals (APD) 66.16B 124.31 4.63 2.43%
PPG Industries (PPG) 25.87B 16.71 3.05 2.45%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value61.51 Economic moatNone UncertaintyLow

Trading 33.0% below Morningstar's fair value estimate.

Fair value

H.B. Fuller Co receives a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 20% discount to our quantitative fair value estimate of $61.51 per share, which is reinforced by this estimate's low uncertainty rating.

The firm's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 80.8%, which falls in the top 40% globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 9.6%, a core component of profitability, ranks in the top 30% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

H.B. Fuller discussion 0 comments

Add a comment